Ion Beam Applications
13.86
14-February-25 11:18:46
15 minutes delayed
Stocks
+0.12
+0.87%
Today's range
13.66 - 13.92
ISIN
BE0003766806
Source
Cboe
-
13 Dec 2023 01:00:00 By Nasdaq GlobeNewswire
-
IBA pioneers theranostic advancements, empowering the market to produce Astatine-211
12 Dec 2023 01:00:00 By Nasdaq GlobeNewswire
-
05 Dec 2023 01:00:00 By Nasdaq GlobeNewswire
-
IBA Business Update – Third Quarter 2023
16 Nov 2023 01:00:00 By Nasdaq GlobeNewswire
-
Iba – Transparency Notification
26 Oct 2023 12:00:00 By Nasdaq GlobeNewswire
-
IBA plans total system restoration on its first-ever proton therapy installation
18 Oct 2023 01:00:00 By Nasdaq GlobeNewswire
-
27 Sep 2023 08:00:00 By Nasdaq GlobeNewswire
-
IBA – Transparency Notification
20 Sep 2023 12:00:00 By Nasdaq GlobeNewswire
-
12 Sep 2023 12:45:00 By Nasdaq GlobeNewswire
-
07 Sep 2023 12:35:00 By Nasdaq GlobeNewswire
-
Iba – Transparency Notification
31 Aug 2023 12:00:00 By Nasdaq GlobeNewswire
-
IBA Reports Half Year 2023 Results
31 Aug 2023 01:00:00 By Nasdaq GlobeNewswire
-
IBA Notice of Half Year 2023 Results and Conference Call
27 Jul 2023 05:00:00 By Nasdaq GlobeNewswire
-
PanTera and TerraPower Isotopes join forces to accelerate access to actinium-225
26 Jun 2023 06:55:31 By Nasdaq GlobeNewswire
-
IBA and PARTICLE initiate FLASH proton therapy Research Partnership
15 Jun 2023 09:00:00 By Nasdaq GlobeNewswire
-
13 Jun 2023 01:00:00 By Nasdaq GlobeNewswire
-
22 May 2023 01:00:00 By Nasdaq GlobeNewswire
-
IBA Business Update – First Quarter 2023
17 May 2023 01:00:00 By Nasdaq GlobeNewswire
-
IBA Reports Full Year 2022 Results
23 Mar 2023 02:00:00 By Nasdaq GlobeNewswire
-
IBA is looking for 100 new collaborators in Belgium by June 2023
14 Mar 2023 09:00:00 By Nasdaq GlobeNewswire